Global Longlife Hospital And Research Ltd (BSE: 543520) is a Ahmedabad, Gujarat-based company in the Hospitals and Healthcare Centers industry. With a market capitalisation of ₹14 Cr, it ranks #4,851 by market cap among the 6,137 Indian listed companies on FinBizNet, and #39 of 42 in Hospitals and Healthcare Centers. At ₹12.57 (as of 25 Oct 2026), the share price is 51.3% below its 52-week high of ₹25.80 and 39.7% above its 52-week low of ₹9.00. The share price is down 49.7% over one year and up 3.0% over three months.
| Current Price | ₹12.57 |
|---|---|
| Market Cap | ₹14 Cr |
| BSE Code | 543520 |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Facilities > Hospitals and Healthcare Centers |
| P/E Ratio | -7.8 |
| Return on Equity | -6.80% |
| Return on Assets | -2.45% |
| 52-Week Range | ₹9.00 – ₹25.80 |
| 1-Year Price Change | -49.7% |
| 3-Month Price Change | +3.0% |
| Beta (1Y) | 0.17 |
| Headquarters | Ahmedabad, Gujarat |
| Website | globalhospital.co.in |
Global Longlife Hospital and Research Limited, a multi-speciality tertiary care hospital, provides medical and surgical specialities services in India. The company offers medical services, such as oncology, ophthalmology, allergy and immunology, pain management, pulmonology, anaesthesiology, cardiology, dermatology, critical care, diabetes and endocrinology, GI medicine, gynecology, infectious disease, nephrology, and neurology; and surgical services, including CVTS, joint replacement orthopaedics, spine surgery, general surgery, onco surgery, GI surgery, neurosurgery, ENT, plastic surgery, trauma centre, urology, laparoscopic surgery, gynaecology, dental surgery, and vascular surgery. It also provides radiology services comprising mammography, CT scan, X-ray, ultrasound, endoscopy, and sonography; pathology services, such as microbiology, biochemistry, clinical pathology, cyto pathology, haematology, and serology; and other services that include dialysis, pharmacy, ambulance, dietary,
1. Healthcare Facilities & Services-This segment engages in the multispecialty hospital business.
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Apollo Hospitals Enterprise Limited | ₹1,13,446 Cr | 57 | 21.50% | ₹7,044 Cr | -1.3% |
| Manipal Health Enterprises Ltd | ₹84,500 Cr | 82.1 | — | ₹3,091 Cr | — |
| Max Healthcare Institute Ltd | ₹82,242 Cr | 56.3 | 14.33% | ₹2,366 Cr | -30.7% |
| Aster Dm Healthcare Limited (Asterdm) | ₹58,702 Cr | 88.7 | 10.07% | ₹1,311 Cr | -7.8% |
| Fortis Healthcare Ltd. | ₹55,603 Cr | 53.3 | 11.01% | ₹2,545 Cr | -34.9% |
| Global Health Ltd (Medanta) | ₹33,340 Cr | 60 | 15.03% | ₹1,304 Cr | -15.1% |
| Krishna Institute Of Medical Science (KIMS) | ₹27,434 Cr | 112.5 | 9.72% | ₹1,180 Cr | -9.4% |
| Dr. Agarwal's Health Care Limited | ₹14,767 Cr | 112 | 8.31% | ₹614 Cr | -9.3% |
| Global Longlife Hospital And Research Ltd | ₹14 Cr | -7.8 | -6.80% | — | -49.7% |
Listed by market capitalisation. Ratios are shown for context only.
Global Longlife Hospital And Research Ltd is trading at ₹12.57, with a market capitalisation of ₹14 Cr.
Global Longlife Hospital And Research Ltd operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Facilities > Hospitals and Healthcare Centers).
Global Longlife Hospital And Research Ltd has a P/E of -7.8 and a return on equity of -6.80%.
Global Longlife Hospital And Research Ltd is listed on the BSE under the scrip code 543520.
Global Longlife Hospital And Research Ltd's share price is down 49.7% over one year and up 3.0% over three months. Its 52-week range is ₹9.00 to ₹25.80.
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.